Dexamethasone Solution and Dexamethasone in Mucolox™

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 26, 2020

Primary Completion Date

January 6, 2023

Study Completion Date

January 6, 2023

Conditions
Oral Lichen PlanusMucous Membrane PemphigoidPemphigus VulgarisChronic Graft-versus-host-disease
Interventions
DRUG

dexamethasone 0.5mg/5ml solution

Patient with oral ulcerative conditions will be asked to rinse with dexamethasone 0.5mg/5ml solution three times a day for 4 weeks and expectorate

DRUG

dexamethasone 0.5mg/5ml solution in Mucolox™

Patient with oral ulcerative conditions will be asked to rinse with dexamethasone 0.5mg/5ml solution in Mucolox™ three times a day for 4 weeks and expectorate

Trial Locations (1)

94117

Sol Silverman Oral Medicine Clinic - UCSF, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT04540133 - Dexamethasone Solution and Dexamethasone in Mucolox™ | Biotech Hunter | Biotech Hunter